Alterity Therapeutics (ATHE) Stock Chart & Stock Price History $4.17 +0.16 (+3.99%) Closing price 05/22/2025 03:44 PM EasternExtended Trading$4.19 +0.02 (+0.38%) As of 06:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alterity Therapeutics Stock Price Performance The Alterity Therapeutics (ATHE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 114.98%, with a year-to-date return of 25.98%. In the past month, the stock has increased 17.80%, reflecting recent market activity. As of the latest close, Alterity Therapeutics traded at $4.17 with a market cap of $36.98 million and volume of 15,751 shares. Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.51%1 Month Performance+17.80%3 Month Performance+2.21%Year-To-Date Performance+25.98%1 Year Performance+114.98% ATHE Stock Chart for Friday, May, 23, 2025 ATHE Chart by TradingView Alterity Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$4.01$4.17+3.99%$4.24$4.0215,751 shs$36.98 million05/21/2025$4.20$4.01-4.52%$4.25$3.925,263 shs$35.56 million05/20/2025$4.05$4.20+3.70%$4.26$3.9428,718 shs$37.24 million05/19/2025$3.99$4.05+1.50%$4.10$3.8155,910 shs$35.91 million05/16/2025$3.79$3.99+5.28%$4.05$3.7827,919 shs$35.38 million05/15/2025$4.10$3.79-7.56%$3.90$3.7133,495 shs$33.61 million05/14/2025$4.15$4.10-1.20%$4.30$4.0432,155 shs$36.36 million05/13/2025$4.39$4.15-5.47%$4.39$4.1527,704 shs$36.80 million05/12/2025$4.80$4.39-8.54%$4.85$4.3541,215 shs$38.93 million05/09/2025$4.23$4.80+13.48%$5.02$4.28152,522 shs$42.56 million Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$3.95$4.23+7.09%$4.39$4.0162,596 shs$37.51 million05/07/2025$4.11$3.95-3.89%$4.16$3.7065,928 shs$35.03 million05/06/2025$4.35$4.11-5.52%$4.22$3.94175,838 shs$36.44 million05/05/2025$3.43$4.35+27.01%$5.00$3.55997,407 shs$38.57 million05/02/2025$3.41$3.43+0.41%$3.44$3.331,367 shs$30.37 million05/01/2025$3.46$3.41-1.42%$3.45$3.3112,572 shs$30.25 million04/30/2025$3.47$3.46-0.29%$3.48$3.375,551 shs$30.68 million04/29/2025$3.48$3.47-0.29%$3.50$3.3715,117 shs$30.77 million04/28/2025$3.48$3.48$3.56$3.3010,847 shs$30.86 million04/25/2025$3.54$3.48-1.69%$3.55$3.428,057 shs$30.86 million04/24/2025$3.54$3.54$3.54$3.412,758 shs$31.39 million04/23/2025$3.47$3.54+2.02%$3.56$3.4412,277 shs$31.39 million04/22/2025$3.45$3.47+0.58%$3.50$3.3210,307 shs$30.77 million Related Companies FDMT Stock Chart ENGN Stock Chart PBYI Stock Chart KRRO Stock Chart LFVN Stock Chart SLS Stock Chart FTLF Stock Chart NKTX Stock Chart CYBN Stock Chart TNGX Stock Chart Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATHE) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
